We are conducting a design project where the production of Amevive is our topic. We realise that it was subsequently taken off the market due to it's ill effects on the patient. However, any help on processes developed circa 2004/2005 would be appreciated.
Please do not delete without contacting me with an explanation of why. Thank you editor. This is a real question, with real urgency.
Well, I do not see any reason for its withdrawl from the market, as it is strictly to be administered under medical supervision. I feel that it has more to do with the relation between Astellas, US and BIOGEN, since Astellas were getting it manufactured by BIOGEN and only marketing it..
They discovered malignant properties with the drug, and that's why it was recalled and ceased!!
- Badges
- Science topic